Timothy J. Daskivich, MD
4.9
58 Reviews
310-423-4700
Fax: 310-423-1886
4.9
58 Reviews
Timothy J. Daskivich, MD
Scheduling
In person visits
Fax: 310-423-1886
Urology - Third
8635 W Third St #1070W
Los Angeles, CA
34.07402 -118.380782From You
4.9
58 Reviews
Timothy J. Daskivich, MD
Languages
- English,
- Spanish,
Gender
Male
Experience
16 Years
Locations
Experience
Specialties
Area in which a healthcare provider is highly trained and often board certified.
1
- Urology
Programs
Cedars-Sinai clinical programs this provider is part of:
4
Research Areas
Timothy J. Daskivich, MD, MSHPM, is a urologic oncologist in the Cedars-Sinai Urology Academic Program and the director of Health Services Research for the Cedars-Sinai Department of Surgery. His clinical practice includes surgical treatment of cancers of the prostate, kidney, bladder and testis, with a focus on prostate cancer. Dr. Daskivich completed a fellowship in urologic oncology, and he is comprehensively trained in open, laparoscopic and robotic approaches to surgical treatment of urologic cancer. He balances his clinical practice with a passion for health services research, a topic that addresses cost, quality and efficiency of healthcare. His research focuses on life expectancy and its role in treatment decision-making for men with early stage prostate cancer. His work promotes a more personalized approach to care to reduce unnecessary overtreatment, while targeting treatment to those who need it. Dr. Daskivichv has published in Annals of Internal Medicine, Cancer, Archives of Internal Medicine, and the Journal of Urology. His nationally recognized work has received funding from the American Cancer Society and the American Urological Association. Dr. Daskivich's research efforts are highly integrated into his clinical practice, with the overarching goal of optimizing both cure of cancer and quality of life for his patients.
Titles
- Assistant Professor, Surgery
Education & Training
-
UCLA David Geffen School of Medicine
Fellowship - Completed 2015
-
UCLA School of Public Health
Degrees - Completed 2014
-
UCLA David Geffen School of Medicine
Residency - Completed 2012
-
Harvard Medical School
Medical School - Completed 2006
-
Harvard College
Degrees - Completed 2001
Achievements
-
1
Board Certifications
-
10
Awards and Honors
-
6
Publications
Board Certifications
-
Urology
American Board of Urology
Awards and Honors
- Best Abstract, Society of Urologic Oncology Annual Meeting
- Collaborator, RAND Urologic Diseases in America Project
- Resident Director, Accreditation Council for Graduate Medical Education
- John Harvard Scholarship for Academic Excellence
- Resident of the Year in General Surgery, UCLA
- Best Poster, American Urological Association Annual Meeting
- Guy Dalla Riva Award for Excellence in Academic Urology, UCLA
- Karin Grunebaum Oncology Research Fellow, Dana Farber Cancer Institute
- Harvard College Scholarship for Academic Excellence
- Board of Directors, Accreditation Council for Graduate Medical Education
Publications
A full list of this provider’s research publications can be found on their research profile or PubMed.
- Daskivich TJ, Chamie K, Kwan L, Labo J, Dash A, Greenfield S, Litwin MS. Comorbidity and competing risks for mortality in men with prostate cancer. Cancer. 2011;117:4642-4650.
- Daskivich TJ, Chamie K, Kwan L, Labo J, Palvolgyi R, Dash A, Greenfield S, Litwin MS. Overtreatment of men with low-risk prostate cancer and significant comorbidity. Cancer. 2011;117:2058-2066.
- Daskivich TJ, Kang-Hsien, F, Koyama T, Albertsen PC, Goodman M, Hamilton AS, Hoffman RM, Stanford JL, Stroup AM, Litwin MS, et al. Impact of Age, Tumor Risk, and Comorbidity on Competing Risks for Survival in a U.S. Population-Based Cohort of Men with Prostate Cancer. Ann Intern Med. 2013;158:709-717.
- Daskivich TJ, Lai J, Dick AW, Setodji CM, Hanley J, Litwin MS, Saigal, CS; Urologic Diseases in America Project. Comparative effectiveness of aggressive versus non-aggressive treatment for men with early-stage prostate cancer and differing comorbid disease burdens at diagnosis. Cancer. 2014;120:2432-2439.
- Daskivich TJ, Lai J, Dick AW, Steodji CM, Hanley JM, Litwin MS, Saigal CS; Urologic Diseases in America Project. Variation in treatment associated with life expectancy in a population-based cohort of men with early-stage prostate cancer. Cancer. 2014;120(23):3642-3650.
- Daskivich TJ, Kwan L, Dash A, Litwin MS. An Age-Adjusted Comorbidity Index for Prediction of Other-Cause Mortality in Men with Early-Stage Prostate Cancer. J Urol. 2015;194(1):73-78.